Manufacturer of giritinib

Gilteritinib is produced by Astellas Pharma Inc.. Astellas Pharma Inc. is an international pharmaceutical company headquartered in Japan that focuses on developing, manufacturing and marketing innovative medicines to improve the health of patients around the world. The company was established in 2005 by the merger of Japan's Sumitomo Pharmaceuticals and the United States' Fidelity Pharmaceuticals.

Astellas Pharma Inc. is committed to the development and production of various types of drugs, including drugs for cancer, infectious diseases, urinary system diseases, immune diseases and other fields. Giritinib, a targeted therapy drug developed by the company for certain types of acute myeloid leukemia, is one of the company's important products in the field of leukemia treatment.

Astellas Pharma Inc. combines global scientific research, innovative technology and pharmaceutical processes to continuously promote the development and production of new drugs to meet the growing medical needs of patients. As an internationally influential pharmaceutical company, Astellas Pharma Inc. is committed to providing high-quality, safe and effective drugs, providing patients around the world with better treatment options and improving their quality of life.

When producing important drugs for the treatment of leukemia such as giritinib,Astellas Pharma Inc. adheres to strict quality control standards and production processes to ensure the quality and safety of the drugs. At the same time, the company also cooperates with medical research institutions, clinicians and patient groups to continuously improve drug treatment options and improve patient treatment effects and survival rates.

Although giritinib has been launched in the domestic market, unfortunately, it has not yet been included in the scope of medical insurance, which makes its domestic price remain high, as high as more than 20,000 yuan. For more specific pricing, please check directly with your local hospital or pharmacy. In comparison, foreign generic drugs are more affordable, especially those from Laos. The price is about two to three thousand yuan, which is significantly lower than the domestic market price. It is worth mentioning that the ingredients of these generic drugs are highly consistent with those of domestic original drugs.